CClinicalTrials.gg
CompletedNCT01511354Updated Oct 11, 2017

New Stable Isotope Method to Determine Protein Requirements in Critically Ill Children

An observational study in Critically Ill, sponsored by Texas A&M University. Completed at 1 site in United States. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2017-10-11.

Sponsored by Texas A&M University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Ages
Up to 18 Years
Sex
All
01

Study summary

The need for certain components of food (i.e. protein) for critically ill children is not clear. It is important to have critically ill children fed adequately to prevent that their condition becomes worse or that recovery takes longer. Research methods used in the past to investigate the need for protein (Nitrogen Balance calculations), were not sensitive enough in severely ill children. The purpose of this study is to develop a new research method to determine the need for protein in severely ill children. In order to develop this new method, more information is needed on the way the body of these children uses protein in 24-hours. In the present study during 24-hours 8 children of age less than 18 years who are admitted to either the Pediatric ICU or the Cardiovascular ICU. Subjects will receive a standard nutrition, providing an age specific amount of protein (age ≤ 3: 2.52 protein g/kg BW.d; age 4-6: 1.8 protein g/kg BW.d; age > 10: 1.44 protein g/kg BW.d) via tube feeding. They will also receive a mixture of stable isotopes of amino to investigate protein behavior in the body (protein kinetics) both by infusion in their blood and together with the nutrition. Blood will be drawn every 60 minutes during the 24-hour period and the behavior of protein and the concentrations in blood of amino acids and urea will be measured. Urine will be collected to measure nitrogen balance. The investigators will compare the results of this nitrogen balance method with the results of the stable isotope method. PIM2, PRISM, SIRS criteria will be used to get information on the severity of illness of the subjects. Also body weight and length as well as body composition of the subjects will be measured at the start and after the 24-hour period. Body composition will be measured by Bioelectrical Impedance Spectroscopy. Endpoints of the study are net whole-body protein synthesis (protein balance), 24-hour pattern of protein balance, 24-hour urea production, 24-hour nitrogen balance, 24-hour contribution of arginine kinetics to whole body protein breakdown, 24-hour muscle protein breakdown, splanchnic amino acid extraction and plasma amino acid concentrations.

02

Conditions studied

  • Critically Ill

Browse trials for

Keywords

  • critically ill children
  • ICU
  • 24hr protein balance
  • stable isotopes
  • fed state
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 12 is below the median of 130 across 867 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Texas A&M University is the lead sponsor of 123 studies on the registry; 23 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Stable critically ill children admitted to the Pediatric Intensive Care Unit or Cardiovascular Intensive Care Unit of ACH

Inclusion criteria

  1. Critically ill children with age less than 18 years at the time of enrollment
  2. Admitted to the Pediatric ICU or Cardiovascular ICU, with an expected stay of >72 hours
  3. One arterial line (or umbilical arterial line) and one multi-lumen central venous line (or two peripheral venous catheters) in place.
  4. Continuous total parenteral nutrition or continuous enteral feeding (e.g. via nasogastric, nasoduodenal, gastric, jejunal tube) with standard nutrition appropriate for age and weight expected during admission.
  5. No planned major changes or interventions (such as surgery) in the treatment and care of the patient from enrollment to completion of study period (end of 24-hour stable isotope infusion protocol).
  6. Hemodynamic stable condition (with or without continuous inotropic medication) defined as ≤1 boluses of volume resuscitation for hypotension in 24 hour.
  7. No significant loss of plasma/blood from wounds or drains, that may influence the results of the study, no chylothorax.
  8. Informed consent by parent(s) or LAR.

Exclusion criteria

Exclusion Criteria:

  1. Congenital/acquired metabolic or endocrine disorders or hepatic or renal failure or anuria or oliguria.
  2. Gastrointestinal obstructions or any condition that causes malabsorption.
  3. Active gastro-intestinal bleeding.
  4. Fluid restriction (\<100 ml/kg BW.day) making administration of intravenous and enteral stable isotopes impossible.
  5. Any other condition that according to the Principal Investigator or study physician would interfere with collecting study samples (for example isolation due to MRSA infection).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (actual)

Groups and cohorts

  • Standard clinical care

    Standard nutritional therapy and treatment

06

What researchers measure

Primary outcomes

  1. Whole body protein synthesis rate

    Whole body protein synthesis rate in the fed state

    Time frame: 24 hours

Secondary outcomes

  1. Whole body protein breakdown rate

    Whole body protein breakdown rate in the fed state

    Time frame: 24 hours

  2. Whole body protein breakdown rate

    Whole body myofibrillar protein breakdown rate in the fed state

    Time frame: 24 hours

  3. Whole body Arginine production rate

    Net whole body arginine production rate in the fed state

    Time frame: 24 h

  4. Splanchnic amino acid extraction

    Splanchnic amino acid extraction in the fed state

    Time frame: 24 hr

  5. Urea production

    Whole body urea production in the fed state

    Time frame: 24 hr

  6. Plasma amino acid levels

    Plasme amino acid level in the fed state

    Time frame: 24 hr

07

Study locations

1 site
  • Arkansas Children's Hospital
    Little Rock, Arkansas 72202, United States
08

References and documents

Publications

  • de Betue CTI, Garcia Casal XC, van Waardenburg DA, Schexnayder SM, Joosten KFM, Deutz NEP, Engelen MPKJ. 24-Hour protein, arginine and citrulline metabolism in fed critically ill children - A stable isotope tracer study. Clin Nutr. 2017 Jun;36(3):876-887. doi: 10.1016/j.clnu.2016.12.023. Epub 2017 Jan 4. PubMed 28089618 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 11, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01511354
Lead sponsor
Texas A&M University
Collaborators
Arkansas Children's Hospital Research Institute
Responsible party
Marielle PKJ Engelen, PhD (PhD, Texas A&M University) — Principal investigator
First posted
Jan 18, 2012
Start date
Feb 2008
Primary completion
Dec 2012
Completion
Jan 2013
Last update
Oct 11, 2017

Study contacts

Marielle P Engelen, PhD
principal investigator · University of Arkansas

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion